DOD Biotech PCL

DOD Biotech PCL Current Assets

The Current Assets of DOD Biotech PCL (DOD.BK) as of Oct 10, 2026 is 425.15 M THB. In the previous year, Current Assets was 574.45 M THB — a change of -25.99% (lower).

Current Assets

425.15 MTHB

YoY

-25.99%

Last updated:

Current Assets of DOD Biotech PCL is 2025 425.15 M THB. Current Assets of DOD Biotech PCL was 2024 574.45 M THB. It decreases by -25.99% lower compared to the previous year.

The DOD Biotech PCL Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
533.90 M THB
Jan 1, 2019
440.08 M THB
Jan 1, 2020
673.40 M THB
Jan 1, 2021
625.98 M THB
Jan 1, 2022
196.56 M THB
Jan 1, 2023
260.40 M THB
Jan 1, 2024
574.45 M THB
Jan 1, 2025
425.15 M THB
The DOD Biotech PCL Current Assets history
YEARCurrent AssetsYoY
425.15 MTHB-25.99%
574.45 MTHB+120.60%
260.40 MTHB+32.48%
196.56 MTHB-68.60%
625.98 MTHB-7.04%
673.40 MTHB+53.02%
440.08 MTHB-17.57%
533.90 MTHB+344.14%
120.21 MTHB-34.19%
182.65 MTHB+23.88%
147.43 MTHB+173.28%
53.95 MTHB+31,944.01%
168,362.00THB—
Access this data via the Eulerpool API

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

Current Assets of DOD Biotech PCL is 425.15 M THB in 2025.

Current Assets of DOD Biotech PCL changed from 574.45 M THB to 425.15 M THB, representing a -25.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's DOD Biotech PCL historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — DOD Biotech PCL

All Key Metrics — DOD Biotech PCL